IP Library Assignment 050260/0228
Patent Assignment
Reel/Frame 050260/0228

Assignment of Assignor's Interest

Recorded: 2019-09-04 Pages: 3
Assignor
UCB S.A.
Executed: 2019-08-29
Assignee
UCB PHARMA S.A.
ALLEE DE LA RECHERCHE, 60, BRUSSELS, B-1070, BELGIUM
Covered Property (1)
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
Application: 16/086,408 →
Publication: US 2019/0100525
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 4, 2019
From: HEER, JAG PAUL
To: UCB BIOPHARMA SPRL
Reel/Frame 050259/0904 →
Assignment of Assignor's Interest Sep 4, 2019
From: DELIGNY, MICHAEL LOUIS ROBERT; LEPISSIER, LUCE ELSA; KEYAERTS, JEAN
To: UCB BIOPHARMA SPRL
Reel/Frame 050260/0178 →
Assignment of Assignor's Interest Sep 4, 2019
From: LOWE, MARTIN ALEXANDER
To: CELLTECH R&D LIMITED
Reel/Frame 050260/0202 →
Assignment of Assignor's Interest Sep 4, 2019
From: CELLTECH R&D LIMITED
To: UCB S.A.
Reel/Frame 050260/0212 →
Assignment of Assignor's Interest Sep 4, 2019
From: UCB PHARMA S.A.
To: UCB BIOPHARMA SPRL
Reel/Frame 050260/0252 →
Assignment of Undivided Interest Sep 12, 2019
From: UCB BIOPHARMA SPRL
To: SANOFI; UCB BIOPHARMA SPRL
Reel/Frame 050355/0873 →
Change of Name Mar 19, 2020
From: UCB BIOPHARMA SPRL
To: UCB BIOPHARMA SRL
Reel/Frame 052191/0142 →